The therapeutic impact of new migraine discoveries

Current Medicinal Chemistry
Laszlo VécseiLars Edvinsson

Abstract

Migraine is one the most disabling neurological conditions and associates with high socio-economic costs. Though certain aspects of the pathomechanism of migraine are still incompletely understood, the leading hypothesis implicates the role of the activation of the trigeminovascular system. Triptans are considered the current gold standard therapy for migraine attacks; however, their use in clinical practice is limited. Prophylactic treatment includes non-specific approaches for migraine prevention. All these support the need for future studies in order to develop innovative anti-migraine drugs. The present study is a review of the current literature regarding new therapeutic lines in migraine research. A systematic literature search in the database of PUBMED was conducted concerning therapeutic strategies in migraine published until July 2017. Ongoing clinical trials with 5-HT1F receptor agonists and glutamate receptor antagonists offer promising new aspects for acute migraine treatment. Monoclonal antibodies against CGRP and the CGRP receptor are revolutionary in preventive treatment; however, further long-term studies are needed to test their tolerability. Preclinical studies show positive results with PACAP- and kynurenic a...Continue Reading

References

Nov 1, 1991·Cephalalgia : an International Journal of Headache·J N Blau
Jan 1, 1986·Advances in Experimental Medicine and Biology·F SicuteriP Geppetti
Jan 1, 1989·British Journal of Pharmacology·W FeniukM J Perren
Oct 16, 1989·Biochemical and Biophysical Research Communications·A MiyataD H Coy
Dec 1, 1986·FEBS Letters·P H SteenberghH S Jansz
Dec 1, 1987·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·L EdvinssonR Uddman
Sep 1, 1995·Naunyn-Schmiedeberg's Archives of Pharmacology·C Waeber, M A Moskowitz
Oct 1, 1996·Brain : a Journal of Neurology·K L HoskinP J Goadsby
Jun 5, 1997·European Journal of Pharmacology·D J WilliamsonR J Hargreaves
Jun 1, 1997·Cephalalgia : an International Journal of Headache·D J WilliamsonS L Shepheard
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·L de LeceaJ G Sutcliffe
Jun 22, 1999·Cephalalgia : an International Journal of Headache·S O'QuinnA W Fox
Jul 21, 1999·Journal of the Autonomic Nervous System·J TajtiL Edvinsson
Aug 24, 1999·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Z CohenE Hamel
Dec 28, 1999·Brain : a Journal of Neurology·P Tfelt-HansenP J Goadsby
Feb 11, 2000·Cephalalgia : an International Journal of Headache·S ShepheardR Hargreaves
Jun 26, 2001·Cephalalgia : an International Journal of Headache·J TajtiL Edvinsson
Jun 26, 2001·Cephalalgia : an International Journal of Headache·D J GoldsteinR E Ryan
Jun 30, 2001·Brain Research·A GorjiE J Speckmann
Nov 20, 2001·Current Opinion in Pharmacology·D K LeeB F O'Dowd
Jan 30, 2002·Bioorganic & Medicinal Chemistry Letters·Harold A WalshNigel P Botting
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Daisuke TsuchiyaKosuke Morikawa
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·Daniel HoyerGraeme R Martin
Apr 26, 2002·Cephalalgia : an International Journal of Headache·R UddmanL Edvinsson

❮ Previous
Next ❯

Citations

May 6, 2019·Expert Review of Neurotherapeutics·János TajtiLászló Vécsei
Jan 5, 2021·Frontiers in Physiology·Michael J M FischerArpad Szallasi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.